These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 8013413
1. Selective induction of DNA synthesis in mouse preneoplastic and neoplastic hepatic lesions after exposure to phenobarbital. Klaunig JE. Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):235-9. PubMed ID: 8013413 [Abstract] [Full Text] [Related]
2. Phenobarbital promotion in diethylnitrosamine-initiated infant B6C3F1 mice: influence of gender. Weghorst CM, Klaunig JE. Carcinogenesis; 1989 Mar; 10(3):609-12. PubMed ID: 2924405 [Abstract] [Full Text] [Related]
3. Gender-dependent differences in hepatic tumor promotion in diethylnitrosamine initiated infant B6C3F1 mice by alpha-hexachlorocyclohexane. Siglin JC, Weghorst CM, Rodwell DE, Klaunig JE. J Toxicol Environ Health; 1995 Feb; 44(2):235-45. PubMed ID: 7531777 [Abstract] [Full Text] [Related]
4. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital. Tamano S, Merlino GT, Ward JM. Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571 [Abstract] [Full Text] [Related]
5. Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Kolaja KL, Stevenson DE, Walborg EF, Klaunig JE. Carcinogenesis; 1996 May; 17(5):947-54. PubMed ID: 8640942 [Abstract] [Full Text] [Related]
6. Mechanism of 1,3-dichloropropene-induced rat liver carcinogenesis. Klaunig JE, Gehen SC, Wang Z, Klein PJ, Billington R. Toxicol Sci; 2015 Jan; 143(1):6-15. PubMed ID: 25354764 [Abstract] [Full Text] [Related]
10. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility. Bursch W, Chabicovsky M, Wastl U, Grasl-Kraupp B, Bukowska K, Taper H, Schulte-Hermann R. Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704 [Abstract] [Full Text] [Related]
13. Comparison in C3H and C3B6F1 mice of the sensitivity to diethylnitrosamine-initiation and phenobarbital-promotion to the extent of cell proliferation. Pereira MA. Carcinogenesis; 1993 Feb; 14(2):299-302. PubMed ID: 8382116 [Abstract] [Full Text] [Related]
14. Reversibility of promoter induced hepatic focal lesion growth in mice. Kolaja KL, Stevenson DE, Walborg EF, Klaunig JE. Carcinogenesis; 1996 Jul; 17(7):1403-9. PubMed ID: 8706241 [Abstract] [Full Text] [Related]
15. Dose-response relationship of diethylnitrosamine-initiated tumors in neonatal balb/c mice: effect of phenobarbital promotion. Klaunig JE, Pereira MA, Ruch RJ, Weghorst CM. Toxicol Pathol; 1988 Jul; 16(3):381-5. PubMed ID: 3194660 [Abstract] [Full Text] [Related]
17. Promotion of hepatocellular foci and adenomas by di(2-ethylhexyl) phthalate and phenobarbital in C3H/HeNCr mice following exposure to N-nitrosodiethylamine at 15 days of age. Weghorst CM, Devor DE, Henneman JR, Ward JM. Exp Toxicol Pathol; 1994 Feb; 45(7):423-31. PubMed ID: 8167465 [Abstract] [Full Text] [Related]